Head-to-head · WeighScore
FormidableMD vs Medsol RX
By GLP-1 ScorecardUpdated
Score comparison
FormidableMD has the higher recorded score — 73.2/100 to 65.8/100.
FormidableMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormidableMD is a physician-led, cash-pay telehealth practice based in Florida offering GLP-1 weight-loss treatment — semaglutide and tirzepatide in both FDA-approved and compounded forms, plus oral options — alongside peptides, HRT/TRT, urgent care, labs, and nutrition coaching.
Before you choose
Before comparing the headline prices, the FormidableMD review and the Medsol RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, FormidableMD vs No BS RX and FuturHealth vs Medsol RX compare each of them with another graded program, and the list of alternatives to FormidableMD ranks the programs closest to FormidableMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | FormidableMD | Medsol RX |
|---|---|---|
| WeighScore | 73.2/100 | 65.8/100 |
| Grade | C | C |
| Site position | #78 | #228 |
| Semaglutide | $169/mo (1 mg dose, compounded) | $169 first month, then $199/mo; six-month plan $894 billed total |
| Tirzepatide | $199/mo (10 mg dose, compounded) | $239 first month, then $259/mo; six-month plan $1,254 billed total |
| Coverage | 1 state | Nationwide delivery claimed; state/treatment eligibility unverified |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
- Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
- Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible
What to consider
- Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
- Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
- The 503A compounding pharmacy partner is not named on the site
Site position #228 · C
Strengths
- Dedicated personal coaching described as included in every plan
- Posted injection schedules distinguish first month, ongoing monthly and prepaid totals
- Prescribing pathway names Open Loop clinicians after consultation
What to consider
- Dose-specific charges, post-term renewal and assigned dispensing pharmacy need confirmation
- Cancellation requires 72-hour notice; monthly current/prior charges generally not refunded
- Prepaid refunds cover months with no medication shipped; shipment schedule matters
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.